Immobilizing topoisomerase I on a surface plasmon resonance biosensor chip to screen for inhibitors
Open Access
- 17 June 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 17 (1), 49
- https://doi.org/10.1186/1423-0127-17-49
Abstract
Background The topoisomerase I (TopI) reaction intermediate consists of an enzyme covalently linked to a nicked DNA molecule, known as a TopI-DNA complex, that can be trapped by inhibitors and results in failure of re-ligation. Attempts at new derivative designs for TopI inhibition are enthusiastically being pursued, and TopI inhibitors were developed for a variety of applications. Surface plasmon resonance (SPR) was recently used in TopI-inhibition studies. However, most such immobilized small molecules or short-sequence nucleotides are used as ligands onto sensor chips, and TopI was used as the analyte that flowed through the sensor chip. Methods We established a sensor chip on which the TopI protein is immobilized to evaluate TopI inhibition by SPR. Camptothecin (CPT) targeting the DNA-TopI complex was used as a representative inhibitor to validate this label-free method. Results Purified recombinant human TopI was covalently coupled to the sensor chip for the SPR assay. The binding of anti-human (h)TopI antibodies and plasmid pUC19, respectively, to the immobilized hTopI was observed with dose-dependent increases in resonance units (RU) suggesting that the immobilized hTopI retains its DNA-binding activity. Neither CPT nor evodiamine alone in the analyte flowing through the sensor chip showed a significant increase in RU. The combination of pUC19 and TopI inhibitors as the analyte flowing through the sensor chip caused increases in RU. This confirms its reliability for binding kinetic studies of DNA-TopI binders for interaction and for primary screening of TopI inhibitors. Conclusions TopI immobilized on the chip retained its bioactivities of DNA binding and catalysis of intermediates of the DNA-TopI complex. This provides DNA-TopI binders for interaction and primary screening with a label-free method. In addition, this biochip can also ensure the reliability of binding kinetic studies of TopI.Keywords
This publication has 31 references indexed in Scilit:
- Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication ForksJournal of Biological Chemistry, 2009
- DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial InhibitionChemical Reviews, 2009
- Formation of Dynamic γ-H2AX Domains along Broken DNA Strands Is Distinctly Regulated by ATM and MDC1 and Dependent upon H2AX Densities in ChromatinMolecular Cell, 2009
- Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I ActivityMolecules, 2009
- DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsyNeuroscience, 2008
- Par-4 Binds to Topoisomerase 1 and Attenuates Its DNA Relaxation ActivityCancer Research, 2008
- Kinetic analysis of human topoisomerase IIα and β DNA binding by surface plasmon resonanceFEBS Letters, 2003
- Interaction of Human DNA Topoisomerase II α with DNA: Quantification by Surface Plasmon ResonanceBiochemistry, 2002
- Functional cooperation between topoisomerase I and single strand DNA-binding proteinJournal of Molecular Biology, 2001
- Development and validation of a genetic algorithm for flexible dockingJournal of Molecular Biology, 1997